Appointment of Mr. Aditya Agarwal as new Company Secretary & Compliance Officer of the Company and resignation of Ms. Bhawna Rajput from the post of company secretary & Compliance Officer ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Limited has informed the stock exchanges about a change in the position of Company Secretary & Compliance Officer, effective September 12, 2025. Ms. Bhawna Rajput (ACS 72357) has resigned from the post citing pre-occupation in other assignments and has been relieved with immediate effect. In her place, the Board of Directors, at a meeting held on the same day, approved the appointment of Mr. Aditya Agarwal (ACS 53202) as the new Company Secretary & Compliance Officer. Mr. Agarwal is a qualified Company Secretary with an MBA and M.Com degree, experienced in legal, secretarial, and listing compliance matters, and is not related to any existing directors. The disclosure has been made under Regulation 30 of the SEBI Listing Regulations.
This is a routine KMP-level change with an immediate replacement in place, so it should not materially affect operations or shareholder value. The simultaneous appointment ensures no gap in compliance responsibilities, which is positive for governance continuity.